4.3 Article

Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas *

Journal

NEOPLASIA
Volume 23, Issue 6, Pages 594-606

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neo.2021.05.014

Keywords

Head and neck cancer; Extracellular matrix; Collagen Cross-linking; Lysyl hydroxylase 2; Procollagen-Lysine; 2-Oxoglutarate 5-Dioxygenase 2; Metastasis

Categories

Funding

  1. NIH/NIDCR [F31-DE028749]
  2. University Cancer Research Fund (UCRF)
  3. UNC Lineberger Tier 3 Developmental Award
  4. Developmental Research Program Grant from the Yale Head and Neck SPORE NIDCR [P50-DE030707]
  5. NCI Center Core Support Grant [P30-CA016086]
  6. North Carolina Biotech (NCBT) Center [2012-IDG-1006]
  7. NIH [U54-CA156733]
  8. NIEHS [P30-EOS010126]
  9. NCBT [2015-IDG-1007]

Ask authors/readers for more resources

Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer globally, with patient prognosis closely related to tumor metastases and the role of collagen in the tumor microenvironment (TME). Lysyl hydroxylase 2 (LH2) is key in modifying collagen cross-links, affecting HNSCC tumor invasion and metastasis.
Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer worldwide and incidence rates are continuing to rise globally. HNSCC patient prognosis is closely related to the occurrence of tumor metastases, and collagen within the tumor microenvironment (TME) plays a key role in this process. Lysyl hydroxylase 2 (LH2), encoded by the Procollagen-Lysine,2Oxoglutarate 5-Dioxygenase 2 (PLOD2) gene, catalyzes hydroxylation of telopeptidyl lysine (Lys) residues of fibrillar collagens which then undergo subsequent modifications to form stable intermolecular cross-links that change the biomechanical properties (i.e. quality) of the TME. While LH2-catalyzed collagen modification has been implicated in driving tumor progression and metastasis in diverse cancers, little is known about its role in HNSCC progression. Thus, using gain-and loss-of-function studies, we examined the effects of LH2 expression levels on collagen cross-linking and cell behavior in vitro and in vivo using a tractable bioluminescent imaging-based orthotopic xenograft model. We found that LH2 overexpression dramatically increases HNSCC cell migratory and invasive abilities in vitro and that LH2-driven changes in collagen cross-linking robustly induces metastasis in vivo . Specifically, the amount of LH2mediated collagen cross-links increased significantly with PLOD2 overexpression, without affecting the total quantity of collagen cross-links. Conversely, LH2 knockdown significantly blunted HNSCC cells invasive capacity in vitro and metastatic potential in vivo . Thus, regardless of the total quantity of collagen crosslinks, it is the quality of these cross-links that is the key driver of HNSCC tumor metastatic dissemination. These data implicate LH2 as a key regulator of HNSCC tumor invasion and metastasis by modulating collagen cross-link quality and suggest that therapeutic strategies targeting LH2-mediated collagen cross-linking in the TME may be effective in controlling tumor progression and improving disease outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available